{"canonical":"https://abierto.us/vendors/the-institute-for-cancer-research-ff1xvjmdyvr1","key":"FF1XVJMDYVR1","name":"THE INSTITUTE FOR CANCER RESEARCH","uei":"FF1XVJMDYVR1","city":"PHILADELPHIA","state":"PA","awards":8,"obligated":"-16800.00","notices_won":0,"top_agency_name":"National Institutes of Health","top_naics":"541714","cage":"1RAF4","parent_name":"THE INSTITUTE FOR CANCER RESEARCH","also_known_as":[],"country":"USA","actions":13,"first_action":"2025-02-20","last_action":"2026-07-21","breakdowns":{"naics":[{"key":"541714","name":null,"awards":7,"obligated":"0.00"},{"key":"541715","name":null,"awards":1,"obligated":"-16800.00"}],"places":[{"key":"PA","name":null,"awards":6,"obligated":"-16800.00"}],"agencies":[{"key":"7529","name":"National Institutes of Health","awards":8,"obligated":"-16800.00"}],"award_types":[{"key":"DELIVERY ORDER","name":null,"awards":5,"obligated":"0.00"},{"key":"PURCHASE ORDER","name":null,"awards":1,"obligated":"-16800.00"}],"competition":[{"key":"FULL AND OPEN COMPETITION","name":null,"awards":7,"obligated":"0.00"},{"key":"COMPETED UNDER SAP","name":null,"awards":1,"obligated":"-16800.00"}],"product_service_codes":[{"key":"AN12","name":null,"awards":7,"obligated":"0.00"},{"key":"6505","name":null,"awards":1,"obligated":"-16800.00"}]},"awards_list":[{"award_key":"CONT_AWD_75N91022F00001_7529_75N91019D00022_7529","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N91022F00001_7529_75N91019D00022_7529/","piid":"75N91022F00001","parent_piid":"75N91019D00022","award_type":"DELIVERY ORDER","vendor_key":"FF1XVJMDYVR1","recipient_name":"THE INSTITUTE FOR CANCER RESEARCH","recipient_uei":"FF1XVJMDYVR1","recipient_cage":"1RAF4","recipient_city":"PHILADELPHIA","recipient_state":"PA","sub_name":"National Institutes of Health","office_name":"NIH NCI","office_key":"o-75N910","first_action_date":"2025-11-19","last_action_date":"2026-05-12","actions":2,"obligated":"0","current_total_value":"2051148.00","potential_total_value":"2051148.00","naics":"541714","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":null,"offers_received":1,"description":"BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERS TASK ORDER TITLE: VACCINES AGAINST FUSOBACTERIUM FOR FAP-AND LYNCH SYNDROME-ASSOCIATED COLORECTAL CANCER IMMUNOPREVENTION","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_75N91022F00002_7529_75N91019D00022_7529","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N91022F00002_7529_75N91019D00022_7529/","piid":"75N91022F00002","parent_piid":"75N91019D00022","award_type":"DELIVERY ORDER","vendor_key":"FF1XVJMDYVR1","recipient_name":"THE INSTITUTE FOR CANCER RESEARCH","recipient_uei":"FF1XVJMDYVR1","recipient_cage":"1RAF4","recipient_city":"PHILADELPHIA","recipient_state":"PA","sub_name":"National Institutes of Health","office_name":"NIH NCI","office_key":"o-75N910","first_action_date":"2025-07-14","last_action_date":"2026-07-07","actions":3,"obligated":"0","current_total_value":"1237620.00","potential_total_value":"1237620.00","naics":"541714","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":null,"offers_received":1,"description":"BASE CONTRACT TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS TASK ORDER TITLE: NEXT GENERATION GP130/IL-6/STAT3 INHIBITORS FOR THE PREVENTION OF COLITIS-ASSOCIATED COLORECTAL CANCER","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_75N91022F00003_7529_75N91019D00022_7529","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N91022F00003_7529_75N91019D00022_7529/","piid":"75N91022F00003","parent_piid":"75N91019D00022","award_type":"DELIVERY ORDER","vendor_key":"FF1XVJMDYVR1","recipient_name":"THE INSTITUTE FOR CANCER RESEARCH","recipient_uei":"FF1XVJMDYVR1","recipient_cage":"1RAF4","recipient_city":"PHILADELPHIA","recipient_state":"PA","sub_name":"National Institutes of Health","office_name":"NIH NCI","office_key":"o-75N910","first_action_date":"2025-02-20","last_action_date":"2025-12-11","actions":2,"obligated":"0","current_total_value":"948377.00","potential_total_value":"1570991.00","naics":"541714","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":null,"offers_received":1,"description":"TASK ORDER TITLE: MICROBIAL METABOLITE MIMICRY, A NANO-DRUG FOR COLON CANCER PREVENTION PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERS","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_75N91023F00001_7529_75N91019D00022_7529","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N91023F00001_7529_75N91019D00022_7529/","piid":"75N91023F00001","parent_piid":"75N91019D00022","award_type":"DELIVERY ORDER","vendor_key":"FF1XVJMDYVR1","recipient_name":"THE INSTITUTE FOR CANCER RESEARCH","recipient_uei":"FF1XVJMDYVR1","recipient_cage":"1RAF4","recipient_city":"PHILADELPHIA","recipient_state":"PA","sub_name":"National Institutes of Health","office_name":"NIH NCI","office_key":"o-75N910","first_action_date":"2026-01-29","last_action_date":"2026-01-29","actions":1,"obligated":"0","current_total_value":"1038958.00","potential_total_value":"1038958.00","naics":"541714","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":null,"offers_received":1,"description":"COLORECTAL CANCER (CRC) PREVENTION BY UROLITHIN A IN RODENT CRC MODELS","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_75N91023F00003_7529_75N91019D00022_7529","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N91023F00003_7529_75N91019D00022_7529/","piid":"75N91023F00003","parent_piid":"75N91019D00022","award_type":"DELIVERY ORDER","vendor_key":"FF1XVJMDYVR1","recipient_name":"THE INSTITUTE FOR CANCER RESEARCH","recipient_uei":"FF1XVJMDYVR1","recipient_cage":"1RAF4","recipient_city":"PHILADELPHIA","recipient_state":"PA","sub_name":"National Institutes of Health","office_name":"NIH NCI","office_key":"o-75N910","first_action_date":"2026-04-07","last_action_date":"2026-04-07","actions":1,"obligated":"0","current_total_value":"1199274.00","potential_total_value":"1199274.00","naics":"541714","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":null,"offers_received":1,"description":"PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE BIOMARKERS TASK ORDER TITLE: SULFORAPHANE FOR THE PREVENTION OF MALIGNANT MESOTHELIOMA","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_IDV_75N91019D00022_7529","permalink":"https://www.usaspending.gov/award/CONT_IDV_75N91019D00022_7529/","piid":"75N91019D00022","parent_piid":null,"award_type":null,"vendor_key":"FF1XVJMDYVR1","recipient_name":"THE INSTITUTE FOR CANCER RESEARCH","recipient_uei":"FF1XVJMDYVR1","recipient_cage":"1RAF4","recipient_city":"PHILADELPHIA","recipient_state":"PA","sub_name":"National Institutes of Health","office_name":"NIH NCI","office_key":"o-75N910","first_action_date":"2026-07-21","last_action_date":"2026-07-21","actions":1,"obligated":"0","current_total_value":null,"potential_total_value":"74995000.00","naics":"541714","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":9,"description":"EO 14398 PREVENT PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_IDV_75N91024D00003_7529","permalink":"https://www.usaspending.gov/award/CONT_IDV_75N91024D00003_7529/","piid":"75N91024D00003","parent_piid":null,"award_type":null,"vendor_key":"FF1XVJMDYVR1","recipient_name":"THE INSTITUTE FOR CANCER RESEARCH","recipient_uei":"FF1XVJMDYVR1","recipient_cage":"1RAF4","recipient_city":"PHILADELPHIA","recipient_state":"PA","sub_name":"National Institutes of Health","office_name":"NIH NCI","office_key":"o-75N910","first_action_date":"2026-04-28","last_action_date":"2026-06-29","actions":2,"obligated":"0","current_total_value":null,"potential_total_value":"149995000.00","naics":"541714","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":9,"description":"PRECLINICAL EFFICACY & INTERMEDIATE ENDPOINT BIOMARKERS IDIQ CONTRACT IN SUPPORT OF THE PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_75N92E21P00142_7529_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N92E21P00142_7529_-NONE-_-NONE-/","piid":"75N92E21P00142","parent_piid":null,"award_type":"PURCHASE ORDER","vendor_key":"FF1XVJMDYVR1","recipient_name":"THE INSTITUTE FOR CANCER RESEARCH","recipient_uei":"FF1XVJMDYVR1","recipient_cage":"1RAF4","recipient_city":"PHILADELPHIA","recipient_state":"PA","sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NHGRI","office_key":"o-75N92E","first_action_date":"2026-07-06","last_action_date":"2026-07-06","actions":1,"obligated":"-16800.00","current_total_value":"0","potential_total_value":"0","naics":"541715","psc":"6505","extent_competed":"COMPETED UNDER SAP","set_aside":"NO SET ASIDE USED.","offers_received":2,"description":"THE ELNITSKI LAB IS PURCHASING NORMAL, LIVER, AND PROSTATE CANCER PATIENT PLASMA.[21-004028]","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null}],"awards_total":8,"awards_page":1,"won":[],"won_total":0,"solicitations_won":[]}